Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Beleave Inc BLEVF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
Beleave Inc is a vertically integrated Canadian cannabis company. It operates streamlined facilities throughout Canada to cultivate high quality cannabis flower, oil and extracts with funded capacity more than 150,000 kilograms per year. Fully licensed to cultivate and sell medical and recreational cannabis, it is leading the way through research partnerships with universities to bridge the gap between science and tradition and to develop pharma-grade extracts and derivatives. The company is currently developing new product lines as the recreational market is expected to allow for food and beverage-based cannabis products.


GREY:BLEVF - Post by User

Beleave Inc
Bullboard Posts
User Avatar Image
(0)
•••
Comment by Oliviabudqueenon May 11, 2017 7:30pm
133 Views
Post# 26234412

RE:license

RE:license75 cents to a dollar on the volume and it would settle at $3.00 respectively. The next phase will be distribution and revenue growth. They don't plan on dilution. Review the chart. This one is a runner and I've been here since 65 cents. I just accumulate and swing on the high highs and low lows. No plan on selling right now. Their license is not priced in.
Kensin1953 wrote: How much weight does the actual license have on the share price.
Is the assumption that it will go ahead already built into the price?


Bullboard Posts
Dealroom for high-potential pre-IPO opportunities